DiscGenics
PrivateLast Round
Series C
Aug 25, 2020
Total Funding Raised
$79.76M
Company Overview
DiscGenics is a biopharmaceutical company that develops regenerative cell-based therapies to alleviate pain and restore function in patients with degenerative spinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DiscGenics Comparables
Compare DiscGenics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mesoblast Limited | 83% | |
| BioRestorative Therapies, Inc. | 82% | |
| VIVEX Biologics | 81% | |
DiscGenics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 25, 2020 | ||||
| Debt | Apr 14, 2020 | ||||
| Series B | Sep 26, 2017 | ||||
| Series A | Nov 30, 2013 | ||||
| Series A | Oct 5, 2011 |
Key People
Founding team and executive leadership
DiscGenics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NT Investments | Series C, Series B |
| Medical Incubator Japan | Series C |
| Mitsubishi UFJ Capital | Series C, Series B |
| Ci:z Investment LLP | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2025
Opened a cGMP facility for scalable cell manufacturing in Salt Lake City.
- Aug 25, 2020
$50M round led by Ci:z Investment LLP.
DiscGenics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DiscGenics's valuation, stock price, and market status.